Therapeutic Strategies for SLE Involving Cytokines: Mechanism-Oriented Therapies Especially IFN-<svg style="vertical-align:-3.366pt;width:11.5125px;" id="M1" height="14.2" version="1.1" viewBox="0 0 11.5125 14.2" width="11.5125"  xmlns="http://www.w3.org/2000/svg">
	<g transform="matrix(1.25,0,0,-1.25,0,14.2)">
		<g transform="translate(72,-60.64)">
			<text transform="matrix(1,0,0,-1,-71.95,64.04)">
				<tspan style="font-size: 17.93px; " x="0" y="0">𝛾</tspan>
			</text>

		</g>
	</g>
</svg> Targeting Gene Therapy

<table>Class-switcing of immunoglobulin.  Cognate contact of T-B interaction and following stimulation of cytokines determine Ig subclass switching in mouse.</table>

BioMed Research International

fig1

Figure 1

Figure 1: Therapeutic Strategies for SLE Involving Cytokines: Mechanism-Oriented Therapies Especially IFN-<svg style="vertical-align:-3.366pt;width:11.5125px;" id="M1" height="14.2" version="1.1" viewBox="0 0 11.5125 14.2" width="11.5125"  xmlns="http://www.w3.org/2000/svg">
	<g transform="matrix(1.25,0,0,-1.25,0,14.2)">
		<g transform="translate(72,-60.64)">
			<text transform="matrix(1,0,0,-1,-71.95,64.04)">
				<tspan style="font-size: 17.93px; " x="0" y="0">𝛾</tspan>
			</text>

		</g>
	</g>
</svg> Targeting Gene Therapy 

Figure 1 | Therapeutic Strategies for SLE Involving Cytokines: Mechanism-Oriented Therapies Especially IFN-
	
		
			
				𝛾
			

		
	
 Targeting Gene Therapy 

BioMed Research International

Therapeutic Strategies for SLE Involving Cytokines: Mechanism-Oriented Therapies Especially IFN- 𝛾 Targeting Gene Therapy

Figure 1

Therapeutic Strategies for SLE Involving Cytokines: Mechanism-Oriented Therapies Especially IFN- Targeting Gene Therapy